Video

Nonsteroidal Mineralcorticoid Receptor Antagonists in Managing Hyperkalemia

Conference|ASN Kidney Week - American Society of Nephrology Kidney Week

Dr. Cary Boyd-Shiwarski explains how nonsteroidal mineralcorticoid receptor antagonists and novel potassium-binding agents alter the management of hyperkalemia and approaching potassium handling in chronic kidney disease.

Pharmacy Times spoke to Dr. Cary Boyd-Shiwarski about her session at the ASN 2021 conference titled "Mechanisms of Potassium Handling in CKD."

Boyd explained how nonsteroidal mineralcorticoid receptor antagonists and novel potassium-binding agents alter the management of hyperkalemia and approaching potassium handling in chronic kidney disease.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Tired scared retiree man holding chest with anginal symptoms, pallor and diaphoresis at home. Suffering male with cardiac origin pain, prexcordial pressure, arrhythmia risk, urgent medical attention - Image credit: DimaBerlin | stock.adobe.com
Image credit: Sebastian Kaulitzki | stock.adobe.com
Magnified bone marrow biopsy showing plasma cells with irregular nuclei and multiple myeloma tumor cells infiltrating normal hematopoietic tissue
Related Content
Hyperlipidemia concept showing artery with plaque buildup and blood flow disruption in detailed medical illustration
June 13th 2025

Enlicitide Decanoate Demonstrates Meaningful Reductions in LDL-C

Luke Halpern, Assistant Editor
S2. Ep 56: Insights From a Pharmacy Times Peer Exchange: How to Talk the Talk
June 3rd 2025

S2. Ep 56: Insights From a Pharmacy Times Peer Exchange: How to Talk the Talk

Alexandra Gerlach, Associate Editor
Woman with a pink ribbon for breast cancer awareness -- Image credit: Phongsakorn | stock.adobe.com
June 13th 2025

ASCO 2025: Ribociclib With NSAI in HR+/HER– Breast Cancer Improves iDFS, Yields Substantial Work Productivity Gains

Gillian McGovern, Associate Editor
Insights from a Pharmacy Times Peer Exchange: Toxicity Monitoring and Management in Real-World Settings
May 28th 2025

Insights from a Pharmacy Times Peer Exchange: Toxicity Monitoring and Management in Real-World Settings

Alexandra Gerlach, Associate Editor
Blood smears showing increased counts of lymphocytes | Image Credit: © DigitalDruid - stock.adobe.com
June 13th 2025

Five-Year Data Show Sustained Efficacy of Zanubrutinib in CLL With High Response Rates

Alexandra Gerlach, Associate Editor
The Evolving Role of the Pharmacist in HEOR: Bridging Clinical and Economic Evidence
June 13th 2025

The Evolving Role of the Pharmacist in HEOR: Bridging Clinical and Economic Evidence

Muhammad Cheema, PharmD, MPBA